Clinical trials: Overall Mortality
- Condition Overall Mortality
- Funder type Industry (pharma, biotech, devices)
- Age group Children (under 18)
Overall Mortality
Retrospective Follow-up of BIOLUX P-I/-II
The aim is to collect long-term clinical data from 132 patients from Belgium, Germany and Austria who had previously participated in either of the BIOLUX P-I or P-II studies.
- Trial name
- NCT04250909
- Testing
- Passeo-18, Passeo-18 Lux
- Where
- 8 sites in Austria, Belgium and 1 more
- Volunteers
- 132 people
- Sponsor
- Biotronik AG